首页 > 最新文献

Current Opinion in Ophthalmology最新文献

英文 中文
Approach and surgical management of epiretinal membrane. 视网膜前膜入路及手术处理。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-03 DOI: 10.1097/ICU.0000000000001135
Joseph R Abraham, Katherine E Talcott

Purpose of review: Epiretinal membrane (ERM) surgery has undergone significant investigation over the last 2 years including assessment of novel surgical techniques and regarding the necessity of internal limiting membrane (ILM) peeling. This review seeks to highlight the latest literature in regards to ERM surgery from unique ERM profiles to clinical trials of surgical approach.

Recent findings: The summative literature highlight that peeling of ILM may reduce recurrence compared to solely peeling ERM; however, these recurrences tend to be mild and nonvisually significant. Optical coherence tomography (OCT) has been leveraged preoperatively, intra-operatively, and postoperatively to enrich knowledge regarding risk factors for worse visual outcomes and deep learning models that are able to predict the anatomic outcome of ERM surgery after review of the preoperative OCT. There is no significant difference in outcomes between sequential and concurrent ERM surgery with cataract surgery. In uveitis evaluations related to ERM, posterior and intermediate uveitis were most associated with ERM, while in pediatric ERM, extent of diffuseness of central ERM correlated with surgical visual improvements.

Summary: The latest ERM research has richly expanded the literature, allowing surgeons to better predict visual improvements postoperatively. This includes using OCT imaging biomarkers, but there remains a litany of unresolved questions about best surgical practices that are actively undergoing assessment.

回顾目的:在过去的两年中,视网膜外膜(ERM)手术经历了重要的研究,包括评估新的手术技术和关于内限制膜(ILM)剥离的必要性。本综述旨在强调关于ERM手术的最新文献,从独特的ERM概况到手术方法的临床试验。近期研究发现:综述性文献强调,与单纯去除ERM相比,去除ILM可减少复发;然而,这些复发往往是轻微的,无视觉意义。光学相干断层扫描(OCT)已在术前、术中和术后得到充分利用,以丰富有关视力结果恶化的危险因素的知识,以及能够在回顾术前OCT后预测ERM手术解剖结果的深度学习模型。顺序性ERM手术和并发性ERM手术合并白内障手术的结果无显著差异。在与ERM相关的葡萄膜炎评估中,后部和中间葡萄膜炎与ERM最相关,而在儿童ERM中,中央ERM的弥散程度与手术视力改善相关。总结:最新的ERM研究丰富了相关文献,使外科医生能够更好地预测术后视力的改善。这包括使用OCT成像生物标志物,但关于最佳手术实践仍有一系列未解决的问题,这些问题正在积极进行评估。
{"title":"Approach and surgical management of epiretinal membrane.","authors":"Joseph R Abraham, Katherine E Talcott","doi":"10.1097/ICU.0000000000001135","DOIUrl":"10.1097/ICU.0000000000001135","url":null,"abstract":"<p><strong>Purpose of review: </strong>Epiretinal membrane (ERM) surgery has undergone significant investigation over the last 2 years including assessment of novel surgical techniques and regarding the necessity of internal limiting membrane (ILM) peeling. This review seeks to highlight the latest literature in regards to ERM surgery from unique ERM profiles to clinical trials of surgical approach.</p><p><strong>Recent findings: </strong>The summative literature highlight that peeling of ILM may reduce recurrence compared to solely peeling ERM; however, these recurrences tend to be mild and nonvisually significant. Optical coherence tomography (OCT) has been leveraged preoperatively, intra-operatively, and postoperatively to enrich knowledge regarding risk factors for worse visual outcomes and deep learning models that are able to predict the anatomic outcome of ERM surgery after review of the preoperative OCT. There is no significant difference in outcomes between sequential and concurrent ERM surgery with cataract surgery. In uveitis evaluations related to ERM, posterior and intermediate uveitis were most associated with ERM, while in pediatric ERM, extent of diffuseness of central ERM correlated with surgical visual improvements.</p><p><strong>Summary: </strong>The latest ERM research has richly expanded the literature, allowing surgeons to better predict visual improvements postoperatively. This includes using OCT imaging biomarkers, but there remains a litany of unresolved questions about best surgical practices that are actively undergoing assessment.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 3","pages":"205-209"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention and management of postcataract cystoid macular edema. 白内障后黄斑囊样水肿的防治。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-20 DOI: 10.1097/ICU.0000000000001127
Satya S Paruchuri, Raziyeh Mahmoudzadeh, Sydney Wheeler, Jessica Randolph

Purpose of review: This review highlights treatment options, both under investigation and currently available, for treating postcataract macular edema. An update on current clinical studies for postcataract macular edema has been summarized.

Recent findings: Pseudophakic cystoid macular edema (PCME) is a common complication of cataract surgery leading to decreased visual acuity due to inflammation promoting vascular permeability and macular edema. There is no gold standard protocol for treatment with physicians choosing topical NSAIDs and corticosteroids most commonly. Recent developments in a therapeutic approach to PCME include improved delivery methods via implantation and improved drugs and combinational therapies.

Summary: While PCME treatments are poorly studied due to their common sudden resolution without medical intervention, chronic PCME is debilitating for patients. Clinical studies show hope for improved drug delivery methods, practices to prevent potential PCME, and improved therapeutics.

综述目的:本综述强调了正在研究和目前可用的治疗白内障后黄斑水肿的治疗方案。总结了目前白内障后黄斑水肿的最新临床研究。摘要假性晶状体囊样性黄斑水肿(PCME)是白内障手术中一种常见的并发症,由于炎症促进血管通透性和黄斑水肿而导致视力下降。医生通常会选择局部非甾体抗炎药和皮质类固醇,没有治疗的黄金标准方案。PCME治疗方法的最新进展包括通过植入改进的输送方法和改进的药物和联合治疗。摘要:由于PCME通常在没有医疗干预的情况下突然消退,因此对其治疗的研究很少,慢性PCME对患者来说是虚弱的。临床研究表明,改进给药方法、预防潜在PCME的实践和改进治疗方法是有希望的。
{"title":"Prevention and management of postcataract cystoid macular edema.","authors":"Satya S Paruchuri, Raziyeh Mahmoudzadeh, Sydney Wheeler, Jessica Randolph","doi":"10.1097/ICU.0000000000001127","DOIUrl":"10.1097/ICU.0000000000001127","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights treatment options, both under investigation and currently available, for treating postcataract macular edema. An update on current clinical studies for postcataract macular edema has been summarized.</p><p><strong>Recent findings: </strong>Pseudophakic cystoid macular edema (PCME) is a common complication of cataract surgery leading to decreased visual acuity due to inflammation promoting vascular permeability and macular edema. There is no gold standard protocol for treatment with physicians choosing topical NSAIDs and corticosteroids most commonly. Recent developments in a therapeutic approach to PCME include improved delivery methods via implantation and improved drugs and combinational therapies.</p><p><strong>Summary: </strong>While PCME treatments are poorly studied due to their common sudden resolution without medical intervention, chronic PCME is debilitating for patients. Clinical studies show hope for improved drug delivery methods, practices to prevent potential PCME, and improved therapeutics.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"182-188"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143460544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tissue engineering of the vitreous body: recent progress and future trends. 玻璃体组织工程:最新进展及未来趋势。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-07 DOI: 10.1097/ICU.0000000000001125
André Schulz, Stefaniya K Boneva, Clemens Lange, J Sebag

Purpose of review: In contrast to current clinically used tamponades including oils and gases, hydrogels offer a vitreous replacement that has the potential to present a niche for vitreous cells and elevate vitreous substitutes to the level of tissue engineering. This article, therefore, highlights and discusses recent hydrogel-based vitreous replacement strategies as well as the latest progress on vitreous cells, towards the development of a cellularized vitreous substitute.

Recent findings: A variety of different crosslinked hydrogel systems have been recently investigated as preformed and in situ forming vitreous substitutes, based on biopolymers and/or synthetic polymers. In addition, a comprehensive understanding of the precise function and immunological significance of hyalocytes as vitreous macrophages has recently emerged using advanced imaging techniques and high-throughput transcriptional and protein analyses.

Summary: Tissue engineering offers transformative potential for vitreous replacement by combining advanced hydrogel systems with hyalocytes as vitreous cells to further replicate the versatile characteristics and functions of the native vitreous.

综述目的:与目前临床使用的包括油和气体在内的填塞相比,水凝胶提供了一种玻璃体替代品,它有可能为玻璃体细胞提供一个生态位,并将玻璃体替代品提升到组织工程的水平。因此,本文重点讨论了近年来基于水凝胶的玻璃体替代策略以及玻璃体细胞的最新进展,以期开发一种细胞化的玻璃体替代品。最近的研究发现:基于生物聚合物和/或合成聚合物,各种不同的交联水凝胶体系已被研究作为预成型和原位形成的玻璃体替代品。此外,最近利用先进的成像技术和高通量转录和蛋白质分析,对透明细胞作为玻璃体巨噬细胞的精确功能和免疫学意义有了全面的了解。摘要:组织工程通过将先进的水凝胶系统与透明细胞结合作为玻璃体细胞,进一步复制天然玻璃体的多种特性和功能,为玻璃体替代提供了变革的潜力。
{"title":"Tissue engineering of the vitreous body: recent progress and future trends.","authors":"André Schulz, Stefaniya K Boneva, Clemens Lange, J Sebag","doi":"10.1097/ICU.0000000000001125","DOIUrl":"10.1097/ICU.0000000000001125","url":null,"abstract":"<p><strong>Purpose of review: </strong>In contrast to current clinically used tamponades including oils and gases, hydrogels offer a vitreous replacement that has the potential to present a niche for vitreous cells and elevate vitreous substitutes to the level of tissue engineering. This article, therefore, highlights and discusses recent hydrogel-based vitreous replacement strategies as well as the latest progress on vitreous cells, towards the development of a cellularized vitreous substitute.</p><p><strong>Recent findings: </strong>A variety of different crosslinked hydrogel systems have been recently investigated as preformed and in situ forming vitreous substitutes, based on biopolymers and/or synthetic polymers. In addition, a comprehensive understanding of the precise function and immunological significance of hyalocytes as vitreous macrophages has recently emerged using advanced imaging techniques and high-throughput transcriptional and protein analyses.</p><p><strong>Summary: </strong>Tissue engineering offers transformative potential for vitreous replacement by combining advanced hydrogel systems with hyalocytes as vitreous cells to further replicate the versatile characteristics and functions of the native vitreous.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"262-269"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution. 糖尿病牵引性视网膜脱离的治疗:来自某大型高等院校的手术经验。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-14 DOI: 10.1097/ICU.0000000000001124
Albert Liao, Blake Fortes, Adrian Au, Kirk Hou

Purpose of review: Management of diabetic tractional retinal detachments (TRDs) remains technically challenging. The purpose of this review is to provide an updated overview of current surgical techniques and important considerations when treating this condition.

Recent findings: Recent advances in imaging have provided critical insights into hyaloid status and tractional forces in diabetic TRDs, greatly aiding surgical planning. Updates in vitrectomy instruments have also greatly improved anatomic success rates. However, a comprehensive preoperative evaluation and plan remains key in optimizing visual outcomes for this difficult condition.

Summary: The surgical management of diabetic TRDs requires several key elements for successful outcomes. Timely intervention and presurgical planning are crucial, particularly in rapidly progressing cases. The use of advanced imaging and instruments enhances visualization and precision during surgery. Finally, a collaborative multispecialty approach with clear communication with patients about their prognosis is fundamental to effective care. These strategies collectively improve patient outcomes and promote visual recovery in those affected by diabetic TRDs.

综述的目的:糖尿病牵引性视网膜脱离(TRDs)的治疗在技术上仍然具有挑战性。本综述的目的是提供当前手术技术的最新概述和治疗这种疾病时的重要注意事项。最近的发现:最近的影像学进展为糖尿病trd的透明体状态和牵引力提供了重要的见解,极大地帮助了手术计划。玻璃体切割仪器的更新也大大提高了解剖成功率。然而,全面的术前评估和计划仍然是优化视力结果的关键。总结:糖尿病trd的手术治疗需要几个关键因素才能获得成功的结果。及时干预和术前计划是至关重要的,特别是在进展迅速的病例中。在手术过程中,先进的成像和仪器的使用提高了可视化和精确性。最后,与患者就其预后进行明确沟通的多专业合作方法是有效护理的基础。这些策略共同改善了患者的预后,促进了糖尿病trd患者的视力恢复。
{"title":"Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution.","authors":"Albert Liao, Blake Fortes, Adrian Au, Kirk Hou","doi":"10.1097/ICU.0000000000001124","DOIUrl":"10.1097/ICU.0000000000001124","url":null,"abstract":"<p><strong>Purpose of review: </strong>Management of diabetic tractional retinal detachments (TRDs) remains technically challenging. The purpose of this review is to provide an updated overview of current surgical techniques and important considerations when treating this condition.</p><p><strong>Recent findings: </strong>Recent advances in imaging have provided critical insights into hyaloid status and tractional forces in diabetic TRDs, greatly aiding surgical planning. Updates in vitrectomy instruments have also greatly improved anatomic success rates. However, a comprehensive preoperative evaluation and plan remains key in optimizing visual outcomes for this difficult condition.</p><p><strong>Summary: </strong>The surgical management of diabetic TRDs requires several key elements for successful outcomes. Timely intervention and presurgical planning are crucial, particularly in rapidly progressing cases. The use of advanced imaging and instruments enhances visualization and precision during surgery. Finally, a collaborative multispecialty approach with clear communication with patients about their prognosis is fundamental to effective care. These strategies collectively improve patient outcomes and promote visual recovery in those affected by diabetic TRDs.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"177-181"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment approaches for refractory full-thickness macular holes. 难治性全层黄斑孔的治疗方法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-06 DOI: 10.1097/ICU.0000000000001131
Nikhil Bommakanti, Roselind Ni, Ajay E Kuriyan

Purpose of review: Full-thickness macular holes (FTMH) can result in significant visual impairment if untreated. Although conventional treatment achieves high closure rates, FTMH can persist or reopen in some cases. This review examines recent advances in surgical approaches for managing refractory FTMH and highlights their effectiveness and limitations.

Recent findings: Approaches to refractory FTMH aim to relieve traction, encourage glial cell proliferation, improve RPE pump efficiency, increase retinal compliance, and/or provide replacement tissue. A variety of techniques targeting these mechanisms, including various autologous or allogeneic transplants such as internal limiting membrane (ILM) or human amniotic membrane grafts, or surgical manipulations such as macular detachment or relaxing retinotomies, have been proposed. These techniques are reviewed here.

Summary: Multiple techniques have shown promise for refractory FTMH. Choice of technique should be guided by characteristics of the FTMH, including size and chronicity, availability of desired tissue or instrumentation, and surgeon familiarity.

综述目的:全层黄斑裂孔(FTMH)如果不及时治疗可导致严重的视力损害。虽然常规治疗可以达到很高的愈合率,但在某些情况下,FTMH可能会持续存在或重新打开。本文回顾了治疗难治性FTMH的手术方法的最新进展,并强调了其有效性和局限性。近期研究发现:治疗难治性FTMH的方法旨在缓解牵引力、促进胶质细胞增殖、提高RPE泵效率、增加视网膜顺应性和/或提供替代组织。针对这些机制的各种技术,包括各种自体或异体移植,如内限制膜(ILM)或人羊膜移植,或手术操作,如黄斑脱离或松弛性视网膜切除术,已经被提出。这里对这些技术进行了回顾。摘要:多种技术已经显示出难治性FTMH的前景。技术的选择应根据FTMH的特点来指导,包括大小和慢性、所需组织或内固定的可用性以及外科医生的熟悉程度。
{"title":"Treatment approaches for refractory full-thickness macular holes.","authors":"Nikhil Bommakanti, Roselind Ni, Ajay E Kuriyan","doi":"10.1097/ICU.0000000000001131","DOIUrl":"10.1097/ICU.0000000000001131","url":null,"abstract":"<p><strong>Purpose of review: </strong>Full-thickness macular holes (FTMH) can result in significant visual impairment if untreated. Although conventional treatment achieves high closure rates, FTMH can persist or reopen in some cases. This review examines recent advances in surgical approaches for managing refractory FTMH and highlights their effectiveness and limitations.</p><p><strong>Recent findings: </strong>Approaches to refractory FTMH aim to relieve traction, encourage glial cell proliferation, improve RPE pump efficiency, increase retinal compliance, and/or provide replacement tissue. A variety of techniques targeting these mechanisms, including various autologous or allogeneic transplants such as internal limiting membrane (ILM) or human amniotic membrane grafts, or surgical manipulations such as macular detachment or relaxing retinotomies, have been proposed. These techniques are reviewed here.</p><p><strong>Summary: </strong>Multiple techniques have shown promise for refractory FTMH. Choice of technique should be guided by characteristics of the FTMH, including size and chronicity, availability of desired tissue or instrumentation, and surgeon familiarity.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"219-226"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial. 社论。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-27 DOI: 10.1097/ICU.0000000000001122
Sunir J Garg, Jason Hsu
{"title":"Editorial.","authors":"Sunir J Garg, Jason Hsu","doi":"10.1097/ICU.0000000000001122","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001122","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 3","pages":"227-228"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising therapeutic targets for neuroprotection in retinal disease. 视网膜疾病神经保护的有前景的治疗靶点。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-10 DOI: 10.1097/ICU.0000000000001123
Warren W Pan, Thomas J Wubben, David N Zacks

Purpose of review: Neurodegeneration is a common endpoint of various blinding retinal diseases. Yet, despite exciting advances in disease treatment, there continues to exist a critical need for the development of neuroprotective strategies to prevent retinal cell death. Here, we summarize the recent advances in neuroprotective strategies.

Recent findings: From laboratory deciphering of the mechanisms involved in disease, many novel neuroprotective strategies have emerged and are currently under investigation for the treatment of various retinal and ocular diseases such as inherited retinal degeneration, retinal detachment, diabetic retinopathy, age-related macular degeneration, macular telangiectasia type 2, and glaucoma. These strategies include gene therapies, Fas inhibition, and targeting inflammatory, metabolic and reduction-oxidation abnormalities. Interestingly, investigation of several treatments across different diseases suggests shared neuroprotection mechanisms that can be targeted regardless of the particular disease.

Summary: Retinal neuroprotection can improve treatment of different retinal diseases. Fortunately, the current landscape, with a plethora of novel neuroprotective therapies, portends a better future for patients.

综述目的:神经变性是各种致盲性视网膜疾病的常见终点。然而,尽管疾病治疗取得了令人兴奋的进展,但仍然迫切需要开发神经保护策略来防止视网膜细胞死亡。在这里,我们总结了神经保护策略的最新进展。最近的发现:从实验室对疾病机制的解读中,许多新的神经保护策略已经出现,目前正在研究用于治疗各种视网膜和眼部疾病,如遗传性视网膜变性、视网膜脱离、糖尿病性视网膜病变、年龄相关性黄斑变性、2型黄斑毛细血管扩张和青光眼。这些策略包括基因治疗、Fas抑制以及针对炎症、代谢和还原氧化异常。有趣的是,对不同疾病的几种治疗方法的研究表明,无论特定疾病如何,都可以针对共同的神经保护机制。摘要:视网膜神经保护可以改善不同视网膜疾病的治疗。幸运的是,目前的情况是,大量新的神经保护疗法预示着患者的未来会更好。
{"title":"Promising therapeutic targets for neuroprotection in retinal disease.","authors":"Warren W Pan, Thomas J Wubben, David N Zacks","doi":"10.1097/ICU.0000000000001123","DOIUrl":"10.1097/ICU.0000000000001123","url":null,"abstract":"<p><strong>Purpose of review: </strong>Neurodegeneration is a common endpoint of various blinding retinal diseases. Yet, despite exciting advances in disease treatment, there continues to exist a critical need for the development of neuroprotective strategies to prevent retinal cell death. Here, we summarize the recent advances in neuroprotective strategies.</p><p><strong>Recent findings: </strong>From laboratory deciphering of the mechanisms involved in disease, many novel neuroprotective strategies have emerged and are currently under investigation for the treatment of various retinal and ocular diseases such as inherited retinal degeneration, retinal detachment, diabetic retinopathy, age-related macular degeneration, macular telangiectasia type 2, and glaucoma. These strategies include gene therapies, Fas inhibition, and targeting inflammatory, metabolic and reduction-oxidation abnormalities. Interestingly, investigation of several treatments across different diseases suggests shared neuroprotection mechanisms that can be targeted regardless of the particular disease.</p><p><strong>Summary: </strong>Retinal neuroprotection can improve treatment of different retinal diseases. Fortunately, the current landscape, with a plethora of novel neuroprotective therapies, portends a better future for patients.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"247-252"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advancements in optic disc pit maculopathy management. 视盘斑窝病治疗的最新进展。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/ICU.0000000000001130
Tadashi Yokoi, Roselind L Ni, Meera D Sivalingam, Yoshihiro Yonekawa

Purpose of review: Optic disc pit maculopathy (ODPM) is a rare yet serious condition that can lead to visual impairment. While pars plana vitrectomy (PPV) remains the gold standard for ODPM that requires treatment, there is ongoing debate regarding adjunctive surgical techniques. This review explores the latest surgical advancements and innovations in the management of ODPM from the past few years.

Recent findings: Vitrectomy remains an effective procedure for ODPM management, achieving high success rates. Adjunctive techniques, including internal limiting membrane (ILM) peeling, gas tamponade, and juxtapapillary laser photocoagulation, have demonstrated efficacy, though their roles remain debated. Novel approaches using ILM plugging, amniotic membrane grafts, and autologous platelet concentrate offer promise, especially in refractory cases. High-level evidence remains scarce, and most recent publications are relatively small case series. Therefore, it remains unclear whether the additional techniques confer additional benefit beyond vitrectomy alone, although the novel approaches can be effective options for refractory cases. Larger comparative studies are required to provide better evidence.

Summary: Vitrectomy with or without additional maneuvers is an effective treatment for ODPM. Emerging adjunctive surgical techniques provide new possibilities, but further research is required to assess for comparative efficacy and optimize outcomes.

回顾目的:视盘斑点病是一种罕见但严重的疾病,可导致视力损害。虽然玻璃体切割(PPV)仍然是需要治疗的ODPM的金标准,但关于辅助手术技术的争论正在进行。这篇综述探讨了过去几年ODPM管理的最新外科进展和创新。最近的研究结果:玻璃体切除术仍然是治疗ODPM的有效方法,成功率很高。辅助技术,包括内限制膜(ILM)剥离、气体填塞和乳头旁激光光凝,已经证明了有效性,尽管它们的作用仍存在争议。新的方法,如ILM堵塞,羊膜移植和自体浓缩血小板提供了希望,特别是在难治性病例。高水平的证据仍然很少,最近的出版物是相对较小的病例系列。因此,除了单纯的玻璃体切除术外,其他技术是否能带来额外的益处尚不清楚,尽管这些新方法对难治性病例是有效的选择。需要更大规模的比较研究来提供更好的证据。总结:玻璃体切除术加或不加其他手术是治疗ODPM的有效方法。新兴的辅助手术技术提供了新的可能性,但需要进一步的研究来评估比较疗效和优化结果。
{"title":"Recent advancements in optic disc pit maculopathy management.","authors":"Tadashi Yokoi, Roselind L Ni, Meera D Sivalingam, Yoshihiro Yonekawa","doi":"10.1097/ICU.0000000000001130","DOIUrl":"10.1097/ICU.0000000000001130","url":null,"abstract":"<p><strong>Purpose of review: </strong>Optic disc pit maculopathy (ODPM) is a rare yet serious condition that can lead to visual impairment. While pars plana vitrectomy (PPV) remains the gold standard for ODPM that requires treatment, there is ongoing debate regarding adjunctive surgical techniques. This review explores the latest surgical advancements and innovations in the management of ODPM from the past few years.</p><p><strong>Recent findings: </strong>Vitrectomy remains an effective procedure for ODPM management, achieving high success rates. Adjunctive techniques, including internal limiting membrane (ILM) peeling, gas tamponade, and juxtapapillary laser photocoagulation, have demonstrated efficacy, though their roles remain debated. Novel approaches using ILM plugging, amniotic membrane grafts, and autologous platelet concentrate offer promise, especially in refractory cases. High-level evidence remains scarce, and most recent publications are relatively small case series. Therefore, it remains unclear whether the additional techniques confer additional benefit beyond vitrectomy alone, although the novel approaches can be effective options for refractory cases. Larger comparative studies are required to provide better evidence.</p><p><strong>Summary: </strong>Vitrectomy with or without additional maneuvers is an effective treatment for ODPM. Emerging adjunctive surgical techniques provide new possibilities, but further research is required to assess for comparative efficacy and optimize outcomes.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"210-218"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial introduction. 编辑介绍。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-02 DOI: 10.1097/ICU.0000000000001114
{"title":"Editorial introduction.","authors":"","doi":"10.1097/ICU.0000000000001114","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001114","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 2","pages":"v"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of myopia in diagnosis and screening of open angle glaucoma. 近视在开角型青光眼诊断和筛查中的意义。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-23 DOI: 10.1097/ICU.0000000000001116
Aiko Iwase, Makoto Araie

Purpose of review: Rapid increase in the prevalence of myopia has been documented worldwide. Myopia, especially high myopia, is not only an important risk factor for having open angle glaucoma (OAG), but also has a strong linking with the progression of OAG. Since myopic axial length (AXL) elongation is associated with nonglaucomatous optic nerve head (ONH) and visual field abnormalities, myopia poses a challenge in differential diagnosis of OAG. This review provides an overview of literature studying relationships between myopic AXL-elongation and diagnosis and prognosis of OAG, and functional and structural changes in the eye.

Recent findings: Studies using optical coherence tomography (OCT), OCT-angiography, those using standard automated perimetry (SAP), other perimetric or electrophysiological methods showed dose-dependent effects of myopic AXL elongation on the structural changes in the ONH and parapapillary tissues, and functional abnormalities of an eye. Large cohort studies showed approximately one quarter of eyes with nonpathologic high myopia were complicated with various patterns of visual field defects including glaucoma-like ones.

Summary: Findings of cross-sectional and longitudinal studies obtained using various fundus imaging devices must be integrated to perimetric results to improve differential diagnosis of OAG in myopic eyes, in which artificial intelligence technology may be useful.

综述目的:世界范围内的近视发病率迅速上升。近视尤其是高度近视不仅是开角型青光眼的重要危险因素,而且与开角型青光眼的发展密切相关。由于近视轴长(AXL)延长与非青光眼性视神经头(ONH)和视野异常有关,因此近视对OAG的鉴别诊断提出了挑战。本文就近视眼axl -伸长与OAG的诊断、预后以及眼内功能和结构变化关系的研究文献进行综述。最新发现:使用光学相干断层扫描(OCT)、OCT血管造影、标准自动视距测量(SAP)、其他视距测量或电生理方法的研究表明,近视AXL伸长对ONH和乳头旁组织的结构变化和眼睛功能异常具有剂量依赖性。大型队列研究显示,约四分之一的非病理性高度近视患者伴有各种类型的视野缺损,包括青光眼样的缺损。摘要:使用各种眼底成像设备所获得的横断面和纵向研究结果必须与周边测量结果相结合,以提高近视眼OAG的鉴别诊断,其中人工智能技术可能有用。
{"title":"Implications of myopia in diagnosis and screening of open angle glaucoma.","authors":"Aiko Iwase, Makoto Araie","doi":"10.1097/ICU.0000000000001116","DOIUrl":"10.1097/ICU.0000000000001116","url":null,"abstract":"<p><strong>Purpose of review: </strong>Rapid increase in the prevalence of myopia has been documented worldwide. Myopia, especially high myopia, is not only an important risk factor for having open angle glaucoma (OAG), but also has a strong linking with the progression of OAG. Since myopic axial length (AXL) elongation is associated with nonglaucomatous optic nerve head (ONH) and visual field abnormalities, myopia poses a challenge in differential diagnosis of OAG. This review provides an overview of literature studying relationships between myopic AXL-elongation and diagnosis and prognosis of OAG, and functional and structural changes in the eye.</p><p><strong>Recent findings: </strong>Studies using optical coherence tomography (OCT), OCT-angiography, those using standard automated perimetry (SAP), other perimetric or electrophysiological methods showed dose-dependent effects of myopic AXL elongation on the structural changes in the ONH and parapapillary tissues, and functional abnormalities of an eye. Large cohort studies showed approximately one quarter of eyes with nonpathologic high myopia were complicated with various patterns of visual field defects including glaucoma-like ones.</p><p><strong>Summary: </strong>Findings of cross-sectional and longitudinal studies obtained using various fundus imaging devices must be integrated to perimetric results to improve differential diagnosis of OAG in myopic eyes, in which artificial intelligence technology may be useful.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"107-114"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1